EP1019697A1 - Dosimetre du rayonnement solaire - Google Patents

Dosimetre du rayonnement solaire

Info

Publication number
EP1019697A1
EP1019697A1 EP98942984A EP98942984A EP1019697A1 EP 1019697 A1 EP1019697 A1 EP 1019697A1 EP 98942984 A EP98942984 A EP 98942984A EP 98942984 A EP98942984 A EP 98942984A EP 1019697 A1 EP1019697 A1 EP 1019697A1
Authority
EP
European Patent Office
Prior art keywords
dosimeter
radiation
matrix
compound
color
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98942984A
Other languages
German (de)
English (en)
Other versions
EP1019697A4 (fr
Inventor
Ori Faran
Ezra Natan
Dmitry Lastochkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Skyrad Ltd
Original Assignee
Skyrad Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/089,252 external-priority patent/US6132681A/en
Application filed by Skyrad Ltd filed Critical Skyrad Ltd
Publication of EP1019697A1 publication Critical patent/EP1019697A1/fr
Publication of EP1019697A4 publication Critical patent/EP1019697A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J1/00—Photometry, e.g. photographic exposure meter
    • G01J1/48—Photometry, e.g. photographic exposure meter using chemical effects
    • G01J1/50—Photometry, e.g. photographic exposure meter using chemical effects using change in colour of an indicator, e.g. actinometer

Definitions

  • the present invention refers to an ultraviolet radiation dosimeter
  • the ultraviolet region is a region of the electromagnetic spectrum adjacent to the low end of the visible spectrum
  • the UV region extends between 400-100 nm, and is divided into 3 sub regions the UVA region (400-320 nm), the UVB region (320-280 nm), and the UVC region (280-100 nm)
  • the exposing to radiation in the UVB region is considered to be the most dangerous to human beings, since it causes several types of the must common cancer in human beings, i e skin cancer
  • One of the types of this cancer, namely melanoma is lethal
  • exposure to radiation in the UVB region can cause skin aging and is also harmful to eyes
  • Radiation in the UVA region mainly causes damage, such as photo-aging, to the skin. Radiation in the UVC region does not penetrate the ozone layer, which inevitably also blocks most of the radiation in the UVB and the UVA region In the last two decades the levels of UV radiation that reach the earth, have increased substantially due to the depletion of the ozone layer, caused by the release of various chemicals in the form of aerosols into the atmosphere
  • UV radiation In some parts of the world the level of UV radiation has increased by 30-50%. The consequence of this process is a substantial increase in the danger of exposure to the sun's radiation It is believed, for example, that every 1% increase in the level of UV radiation, corresponds to a 4% increase in the number of skin cancer cases Indeed, according to medical statistics the number of skin cancer cases has increased by hundreds of percents in the last 20 years UV radiation induces biological effects depending on the particular wavelength of the radiation It is known to evaluate total biological or hazard weighted irradiation by multiplying the spectral irradiation at each wavelength by the biological or hazard weighted factor and then summation results of the multiplying over all the wavelengths
  • Biological or hazard factors are obtained from the so-called action spectrum according to Environmental health criteria 60 "Ultraviolet radiation” issued by the World Health Organization, Geneva, 1994.
  • An action spectrum is a graph of the reciprocal of the radiant exposure required to produce the given harmful effect at each wavelength, A ⁇ the data in such graphs are normalized to the datum at the must efficacious wavelength.
  • the biologically effective radiant exposure efficacy in J/m 2
  • the action spectrum graph for UV induced erythema was adopted worldwide by many organizations such as:
  • the action spectrum graph is a complex curve, obtained by statistical analysis of many research results establishing the minimum radiant exposure to the UN radiation at different wave lengths sufficient for causing erythema.
  • the most commonly used quantity of radiation associated with the erythemal potential due to exposure to UV radiation is the number of so-called minimum erythemal doses (MED) caused by the exposure.
  • An MED is defined as the radiant exposure of the UV radiation that produces a just noticeable erythema on previously unexposed skin.
  • the radiant exposure to monochromatic radiation at around 300 nm with the maximum spectral efficacy, which is required for erythema corresponds to approximately 200 to 2000 J/m 2 efficacy, depending on the skin type.
  • the skin reacts to radiation by changes in the melanin content. Subsequent to the change in the melanin content reddening occurs, and then soreness and signs of sun burning appear.
  • the permissible time for exposure to UV radiation on a mid summer day changes from 15 minutes for skin type no.l, to about 2 hours for skin type no.5 (without using sun screen).
  • Most people are not aware of the danger that can arise even after limited exposure to UV radiation, because the dose is accumulated during the exposing for varying periods of time in a daily life routine.
  • the first visible sign is usually sunburn, which might only become visible after a few hours. This means that the individual becomes aware of the danger only after the damage has already been done. It should be emphasized that skin cancer might even appear years later.
  • UV radiation level changes continuously, because of latitude, air pollution, season of year, clouds, and other factors. Therefore, it is very difficult to give accurate, reliable and timely warnings to the public about the UV radiation levels for specific location and day time.
  • the only practical means that the public can use to defend itself is a personal dosimeter.
  • This dosimeter employs a photo sensitive composition consisting of a discoloring agent, a photo activator and a UV-ray absorber.
  • the photo activator forms free radicals by the irradiation of UV rays and the discoloring agent exhibits a color change in the visible region of a spectrum through the action of free radicals and a UV-ray absorber.
  • the disadvantage of this dosimeter is associated with the fact that its principle of operation, and therefore the compound employed therein, is neither suitable to measure the radiation dose which is equivalent to an MED, nor is it selective to different types of the user's skin.
  • the known dosimeter is designed in such a manner, that the amount of UV-radiation necessary for inducing the color change can be either 1-100 J/cm 2 or 10 "5 J/ cm 2 . These values are far away from the magnitude of UV-radiation corresponding to an MED, which is about 20 mj/cm 2 for skin type no.2. Also known is a method and device for monitoring UV radiation as disclosed in Cybrandian Ltd.'s US patent No. 5117116. In the specification of this patent it is mentioned that to facilitate quantifying the minimum dose of UV radiation an individual can tolerate, the dose of UV radiation which induces reddening in the skin is referred to as the Minimum Erythemal Dose.
  • This dosimeter employs a chemical compound capable of changing its color on being subjected to UV radiation reflected from the skin of the user.
  • the principal disadvantage of this provision is associated with the fact that various types of skin in various conditions reflect differently and therefore cause enormous uncertainty in the determining of the actual dose of UV radiation to which the skin of an individual has been subjected irrespective of whether this dose is attributed as an MED or not.
  • the main aim of the present invention is to provide for a new and improved dosimeter, which is simple, cheap, convenient and is suitable for daily use by individuals.
  • the further object of the present invention is to provide a dosimeter employing active photochromic compound which changes its color after exposure to the sun's radiation with the efficacy of at least 1 MED.
  • the present reversible dosimeter advises the user to terminate exposure to the sun's radiation after the whole dosimeter's surface has changed its initial color to the color that appears at the border of the surface. This coloration signifies that the user has already been exposed to 1 MED radiation.
  • Another object of the present invention is to provide a dosimeter which is equally suitable for use by individuals with different types of skin. Still a further object of the invention is to provide a dosimeter which can be conveniently worn by the user or attached to various equipment.
  • Yet another object of the invention is to provide a dosimeter which in contrast to the known in the art dosimeters does not require the procedure of comparing with a reference chart.
  • Brief description of the drawings WO j 99 y /u14 ⁇ 57 / ⁇ 3 PCT/IL98/00434
  • Fig. 1 shows example of an action spectra graph.
  • Fig. 2 shows the relative intensity of UV solar radiation versus wavelength.
  • Fig. 3 is a graphic illustration of solar radiation efficacy as a function of time.
  • the graph refers to skin type No.2 and corresponds to 1 MED monochromatic radiation with wavelength 297 nm.
  • Figs. 4a,b,c,d,e,f show applications of the new dosimeter which can be either worn by a user or attached to various equipment.
  • Figs. 5a-5e show various cross-sections of the dosimeter in accordance with various embodiments thereof.
  • Figs. 6a-6c schematically show the dynamic output (change of color) ' of the dosimeter as function of the increasing radiation dose received by the dosimeter.
  • Fig. 7 shows the reaction of photochemical dissociation of the carbonyl.
  • Fig. 8 shows the chemical formula of viologens
  • Fig. 9 shows the chemical reaction responsible for change of color which is governed by the electron transfer.
  • Fig.10 shows the chemical formula of spiropyrans and spirooxazines suitable for use in the present invention.
  • Fig.11 shows the chemical reaction governed by the ion mechanism responsible for change of color in spiropyrans and spirooxazines.
  • Fig.12 shows the chemical formula of bisimidazole derivatives suitable for use in the present invention.
  • Fig.13 shows the chemical reaction governed by the mechanism of radical dissociation.
  • the device in accordance with the present invention functions as a dosimeter and not as a detector, it is very important that it be attached to the user's clothing or equipment in such a manner that it absorbs the same amount of sun radiation as that to which the user is exposed.
  • the specific photochromic substances employed in the dosimeter of the present invention are selected in such a manner that they are sensitive to exposure to solar radiation in the UV region, but not necessarily at the wavelengths which corresponds to the peak of action spectrum as shown in fig. 1, because this wavelength band (around 300 nm) is beyond the visible spectrum in which it is desirable that the color change takes place.
  • the desirable wavelength band in which the photochromic compound changes its color should not be too far from the wavelength corresponding to the action spectrum peak. This is required in order to ekminate possible mistakes associated with the extrapolation from the wavelength at which a particular photochromic compound changes its color to the wavelength corresponding to the action spectrum peak.
  • the amount of UV radiation that can present a danger to an individual exposed to the sun's radiation is determined on the basis of existing action spectra and available data for each skin type. An average integral of the intensity of radiation vs. time is calculated from the MED efficacy-time dependence available for monochromatic radiation of 297 nm. An example of this dependency referring to skin type No. 2 is shown in fig. 3.
  • the effective intensity of irradiation at a particular wavelength or band, to which the employed photochromic compound is sensitive is determined from the dependence of UV radiation intensity vs. wavelength.
  • the example of this function is shown in fig. 2. This intensity is then extrapolated to the intensity of an irradiation taking place at 297 nm and at the conditions to which the user will be exposed.
  • the color change of the dosimeter can be induced by exposing the dosimeter to a radiation dose produced by a sun simulator (type 16S, manufactured by Solar Light co.), capable of emitting up to 20 times the sun radiation intensity in the UV region.
  • the simulator is provided with a radiation dose control means that allows to set the radiation in J/m 2 to the desired dose in MED.
  • the dosimeter comprises an active chemical compound capable to undergo photo-chemical reaction accompanied by changing of its color and an absorber. Both the chemical compound and the absorber are distributed within a polymeric matrix.
  • the particular combination of an active chemical compound and an absorber and material of the matrix for use in the dosimeter is chosen in such a manner that the dosimeter changes color during exposure to solar radiation, the efficacy of which exceeded the individual's permissible MED corresponding to his personal skin type
  • Provided in accordance with the invention are up to 5 types of dosimeters which can be combined, each of them capable of responding to solar radiation dose, which is corresponding to 1 MED required for a particular skin type
  • the public's attitude to use such a dosimeter will be more positive and thus there will also be increased awareness of the danger of exposure to UV radiation.
  • the user can also use the dosimeter simultaneously with a sun screen by applying it to the dosimeter surface, and thus increase the permissible time of exposure to the sun's radiation.
  • the dosimeter comprises a polymeric matrix 2.
  • the aim of the matrix is to carry an active chemical compound therein, to reliably protect it from corrosion due to ambient humidity and to impart thereto machinability.
  • the matrix material should be thermally stable, i.e., should not alter its opaqueness after heating up to 50 degrees C so as to retain its transparency sufficient for visualizing the variation of color of an active compound incorporated in the matrix.
  • a suitable matrix material one can use various optically transparent materials, for example polycarbonates, polystyrenes, polyolifines, polyacrylates such as polymethylmethacrylates, polyvinyl derivatives, polyesther derivatives, polyvinyl chloride; cellulose derivatives such as cellulose acetate, polyurethanes, polyethylene terephthalate, silicone resins such as LSR (liquid silicone rubber), triethylene glycole dimethacrylate (TEGDM, commercially known as CR-39), epoxys etc.
  • Transparent copolymers and blends of dissimilar transparent polymers are also suitable as a matrix material.
  • Fig.5a shows the matrix within an active photochromic compound 4 distributed therein.
  • the matrix may contain an UV absorbing material 6 distributed therein.
  • the UV absorber consists of a material that is capable of partially absorbing the UV radiation. By virtue of this provision it becomes possible to control the amount of accumulated radiation to which the active compound is exposed. Examples of materials suitable for use as absorbers include: 2,4-bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-n-octyl-oxyphenyl)-l,3,5-triazine.
  • the active compound and absorbing material can be incorporated within the matrix by means of any known-in-the-art suitable method, for example by compounding or casting.
  • the dosimeters can be manufactured by any known-in-the-art suitable method, for example by injection molding or extrusion.
  • the amount of an active compound or absorbing material within the matrix varies between 0.1 to 10 weight percent depending on the matrix material, type of an active compound and particular type of the user's skin.
  • Fig.5b shows an embodiment of the present invention in which the active compound and absorbing material are substantially homogeneously distributed within the matrix.
  • Fig.5c shows an alternative embodiment of the dosimeter in which the active compound is distributed in one part of the matrix, while the absorbing material is distributed in the other part thereof and there is provided a border line 8 separating there between.
  • the direction and slope of this border line is deliberately chosen so as to create a gradient of thickness of the layer containing the absorber, i.e. a minimum thickness thereof at one lateral side 10 of the dosimeter, which gradually increases to a maximum thickness thereof at the opposite lateral side 12 of the dosimeter.
  • the effective concentration of the active compound also varies along the same border line from being correspondingly at its maximum at the side 10 and at its minimum at the opposite side 12.
  • a dye or an organic pigment in order to impart suitable initial color to the dosimeter surface which could strengthen the contrast with the color of the active material after it has been exposed to the UV radiation.
  • the classes of the organic pigments suitable for this purpose comprise Phtalocyanine, Quinacridone, Isoindolinone, Perylene, Anthraquinone, etc.
  • Figs.5d-e show two additional embodiments of the dosimeter in which the thickness of the absorber containing layer varies.
  • the active compound is distributed in the lower portion 16 of the matrix and its concentration is homogeneous. Within the upper portion 14 of the matrix is distributed the absorbing material and there is deliberately created a gradient of thickness of this portion and thus of the effective concentration of the absorber along a border line 18.
  • the lower and upper layers of the matrix can be made of similar or dissimilar material and thus, one can provide even better control of the dynamic response of the active compound to the UV radiation.
  • Fig. 5e shows the embodiment similar to that shown in fig.
  • the gradient of thickness of the absorber containing matrix is arranged in such a manner that at the left side of the dosimeter the active compound is separated from the upper surface by the matrix with absorber and at the opposite side the active compound is separated from the upper surface solely by the matrix.
  • the active compound should be capable of undergoing photochemical reactions accompanied by coloration in response to cumulative UV radiation of which the efficacy corresponds to at least 1 MED.
  • the photochemical reaction should be accompanied by relatively slow change of the compound's color during at least 15 min (for skin type No. 1) and no longer than during several hours (for skin type No.5).
  • the compound should not change or reverse its color after it has been exposed to the sun radiation for at least 8 hours at a temperature up to 50 C.
  • the reverse reaction should take place after the dosimeter has been kept for several hours in darkness (and no more then one night). The number coloration/discoloration cycles without significant fatigue should be between 10 to 300 depending on the particular application of the dosimeter.
  • the mechanism of photochemical reaction responsible for coloration of the active compound should be at least one mechanism chosen from the group including photochemical dissociation of carbonyl group, electron transfer, formation of ions, and radical dissociation.
  • R 2 , R 3 , R4, R5, 5 , 7 represent independently an alkyl group, an aromatic group, an alkoxy group, a nitro group or a halogen
  • Xi can represent the group CH or the heteroatom N .
  • the chemical reaction governed by the formation of ions is presented with reference to fig. 11.
  • d) Bisimidazoles derivatives for example as described in White, D. M.; Sonnenberg, j J. Org. Chem., 29, 1926 (1964).
  • This group of compounds is represented by the general formula shown in fig 12.
  • R represents a phenyl group, a methylphenyl group, a methoxy phenyl group or Halogen phenyl group.
  • the mechanism of radical dissociation Presented with reference to fig. 13, the mechanism of radical dissociation.
  • Example No. 1 The present invention will now be disclosed with reference to non limiting examples 1-3 below.
  • Example No. 1 The present invention will now be disclosed with reference to non limiting examples 1-3 below.
  • Example No. 1 Example No. 1
  • the dosimeter is designed for skin type No. 2 and has total thickness of 1 mm.
  • the matrix is manufactured in the form of a film by casting from the polymer solution.
  • the lower layer of the matrix is made of PMMA and has thickness 0.5 mm.
  • Distributed within the layer is 4 weight percent of an active photochromic material, which is Chromium-hexacarbonyl.
  • the upper layer has thickness 0.5 mm, made of PMMA.
  • Distributed within this upper layer is 1 weight percent of a UV absorber, which is 2-(2-hydroxy-5-methyl-phenyl)-2H-benzotriazole,
  • the dosimeter in this example refers to an embodiment shown in fig.5c with an upper layer having gradient of thickness. The upper layer is cast separately and then attached to the matrix.
  • the dosimeter changes its color from transparent to yellow after irradiation of 1 MED ( skin type 2).
  • the dosimeter was irradiated by the sun during different day hours and during different seasons.
  • the tests were calibrated by a PMA2100 data logger with a PMA2101 and PMA2102 UVB detectors manufactured by the Solar Light Co.
  • the dosimeter's color is not influenced neither after being held in the sun or light without time limitation, or being held in darkness for at least 5-6 hours, nor at the temperature 50 deg.C. This dosimeter reverts its color 200 times without significant fatigue.
  • Example No. 2 The dosimeter is designed for skin type No. 2 and comprises a matrix made of polystyrene.
  • the total thickness of the dosimeter is 1.5 mm.
  • the matrix in the form of a film is cast from the polymer solution.
  • the lower layer of the matrix has a thickness of 1 mm and contains 3 weight percent of an active compound which is 2,2',4,4',5,5'-hexa-p-Chlorophenyl-bis-imidazole .
  • the upper layer has a thickness of 0. 5 mm and distributed therein is 1.5 weight percent of a UV absorber, which is 2,2'-dihydroxy-4,4'-methoxybenzophenone.
  • the dosimeter according to this example refers to an embodiment shown in fig, 5c with an upper layer having a gradient of thickness.
  • the upper layer is cast separately and then attached to the matrix.
  • the dosimeter changes color from transparent to purple after irradiation of 1 MED (of skin type no.2).
  • the dosimeter was irradiated by the sun during different hours of the day and during different seasons.
  • the tests were calibrated by a PMA2100 data logger with a PMA2101 UVB detector manufactured by Solar Light Co.
  • the dosimeter's color is not influenced neither after being held in the sun or light without time limitation or being held in darkness for at least 6 hours, nor at the temperature 50 deg. C. This dosimeter reverts its color 50 times without significant fatigue.
  • the dosimeter is designed for skin type No. 3 and has the total thickness 0.5 mm.
  • the matrix in the form of a film is cast from the polymer solution.
  • the lower layer of the matrix is made of PVA and contains 2 weight percent of an active compound which is N-Benzyl-N'-n-Propyl-4,4'-Bipyridinium dichloride .
  • the upper layer with an absorber therein is made of PMMA. It has a maximum thickness of 0.25 mm and distributed therein is 0.25 weight percent of an UV absorber, 2-(2-hydroxy-5-methyl-phenyl)-2H-benzotriazole,.
  • the dosimeter according to this example refers to an embodiment shown in fig. 5b with an upper layer having a gradient of thickness.
  • This layer is cast separately and then is attached to the matrix.
  • the dosimeter changes its color from transparent to blue after irradiation of 1 MED.
  • the dosimeter was irradiated by the sun during different hours of the day and during different seasons.
  • the tests were calibrated by a PMA2100 data logger with a PMA2101 UVB detector manufactured by the Solar Light Co.
  • the dosimeter's color is not influenced neither after being held in the sun or light without time limitation, or being held in darkness for at least 6 hours, nor at the temperature 50 deg.C. This dosimeter revert its color 10 times without significant fatigue.
  • the dosimeter of the present invention can be used for measuring the UV dose to which not only people but also to which other objects were exposed, for example, plants or animals in agriculture, various sensible equipment to be exploited at the conditions of exposure to UV radiation, etc. It should be appreciated that the features disclosed in the foregoing description, and/or in the following claims, and/or in the accompanying drawings and/or in the accompanying examples may, both separately and in any combination thereof, be material for realizing the present invention in diverse forms thereof.

Landscapes

  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Photometry And Measurement Of Optical Pulse Characteristics (AREA)
  • Measurement Of Radiation (AREA)

Abstract

La couleur d'origine de ce dosimètre du rayonnement solaire est capable de se modifier du fait d'une réaction chimique provoquée par l'exposition au rayonnement ultraviolet. Ce dosimètre comporte une matrice renfermant un composé chimique capable de réagir à la suite de l'absorption du rayonnement ultraviolet. Ce dosimètre est opérationnel à partir d'au moins 1 dose active minimale accumulée durant au moins 15 minutes d'exposition.
EP98942984A 1997-09-16 1998-09-08 Dosimetre du rayonnement solaire Withdrawn EP1019697A4 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US5904197P 1997-09-16 1997-09-16
US59041P 1997-09-16
US89252 1998-06-03
US09/089,252 US6132681A (en) 1997-09-16 1998-06-03 Disposable dosimeter for sun radiation
US14053198A 1998-08-26 1998-08-26
US140531 1998-08-26
PCT/IL1998/000434 WO1999014573A1 (fr) 1997-09-16 1998-09-08 Dosimetre du rayonnement solaire

Publications (2)

Publication Number Publication Date
EP1019697A1 true EP1019697A1 (fr) 2000-07-19
EP1019697A4 EP1019697A4 (fr) 2002-08-07

Family

ID=27369574

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98942984A Withdrawn EP1019697A4 (fr) 1997-09-16 1998-09-08 Dosimetre du rayonnement solaire

Country Status (3)

Country Link
EP (1) EP1019697A4 (fr)
AU (1) AU9093298A (fr)
WO (1) WO1999014573A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013092334A1 (fr) 2011-12-21 2013-06-27 Sika Technology Ag Dispositif d'entraînement d'un dispositif de dosage et de mélange de substances à plusieurs composants
WO2013092324A1 (fr) 2011-12-21 2013-06-27 Sika Technology Ag Mécanisme d'entraînement d'un dispositif doseur et mélangeur
WO2013092927A1 (fr) 2011-12-21 2013-06-27 Sika Technology Ag Dispositif d'entraînement d'un doseur-mélangeur

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0823282D0 (en) 2008-12-20 2009-01-28 Univ Strathclyde Dose responsive UV indicator
EP3035133A1 (fr) * 2014-12-15 2016-06-22 The Swatch Group Research and Development Ltd. Elément d'habillage avec capteur de luminosité
US11231506B2 (en) 2018-09-14 2022-01-25 Billion Bottle Project Ultraviolet (UV) dosimetry

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130760A (en) * 1977-06-29 1978-12-19 Minnesota Mining And Manufacturing Company Reusable radiation monitor
EP0325863A2 (fr) * 1987-12-28 1989-08-02 Mark S. Depalma Dispositif de mesure du rayonnement ultraviolet à plusieurs couleurs
US5028792A (en) * 1987-03-19 1991-07-02 Xytronyx, Inc. System for the visualization of exposure to ultraviolet radiation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194963A (en) * 1961-07-17 1965-07-13 Sundstrand Corp Light intensity measuring device and method using 2-(2', 4'-dinitrobenzyl)-pyridine
US3787687A (en) * 1972-02-23 1974-01-22 T Trumble Ultraviolet radiation dosimeter
DE69219313T2 (de) * 1992-03-23 1997-11-13 Nippon Telegraph & Telephone UV-A und UV-B trennender Sensor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130760A (en) * 1977-06-29 1978-12-19 Minnesota Mining And Manufacturing Company Reusable radiation monitor
US5028792A (en) * 1987-03-19 1991-07-02 Xytronyx, Inc. System for the visualization of exposure to ultraviolet radiation
EP0325863A2 (fr) * 1987-12-28 1989-08-02 Mark S. Depalma Dispositif de mesure du rayonnement ultraviolet à plusieurs couleurs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9914573A1 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013092334A1 (fr) 2011-12-21 2013-06-27 Sika Technology Ag Dispositif d'entraînement d'un dispositif de dosage et de mélange de substances à plusieurs composants
WO2013092324A1 (fr) 2011-12-21 2013-06-27 Sika Technology Ag Mécanisme d'entraînement d'un dispositif doseur et mélangeur
WO2013092927A1 (fr) 2011-12-21 2013-06-27 Sika Technology Ag Dispositif d'entraînement d'un doseur-mélangeur

Also Published As

Publication number Publication date
AU9093298A (en) 1999-04-05
EP1019697A4 (fr) 2002-08-07
WO1999014573A1 (fr) 1999-03-25

Similar Documents

Publication Publication Date Title
US6132681A (en) Disposable dosimeter for sun radiation
US8961897B2 (en) Disposable measuring device for UV radiation
US3903423A (en) Sunburn dosimeter
US5581090A (en) Photochromic ultraviolet detector
US6060321A (en) Sun tan dosimeter
US20050285050A1 (en) Sun sensor, an article incorporating the sun sensor and methods of preparation and use
CA2282084C (fr) Dispositif indicateur de rayonnement
CA2782492C (fr) Indicateur d'ultraviolet sensible a une dose
US6437346B1 (en) Solar blind-UVC photochromic detector and method for calibration
US20010019110A1 (en) Dosimeter for sun radiation
Butson et al. Ultraviolet radiation dosimetry with radiochromic film
US20040109789A1 (en) Dosimeter for sun radiation for use with sunscreen lotion
US5731589A (en) Ultraviolet radiation dosimeter
EP1019697A1 (fr) Dosimetre du rayonnement solaire
US4212535A (en) Ultraviolet radiation dosimeter
Mills et al. UV dosimeters based on neotetrazolium chloride
Wong et al. A new dosimeter for ultraviolet‐B radiation
Ebraheem et al. Polymer-based triphenyl tetrazolium chloride films for ultraviolet radiation monitoring
Knuschke UV exposure
Rettberg et al. The DLR-Biofilm as personal UV dosimeter
Yang et al. Materials and Device Design for Epidermal UV Sensors with Real‐Time, Skin‐Color Specific, and Naked‐Eye Quasi‐Quantitative Monitoring Capabilities
Sidney et al. A new radiochromic dosimeter film
Fanselow et al. Reusable ultraviolet monitors: Design, characteristics, and efficacy
Rehim et al. The use of Riso B3 film gamma dosimeter for monitoring ultraviolet radiation
Abukassem et al. Radiometric characterization of radiochromic gel material applied for UVA radiation dosimetry

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000417

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020624

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7G 01N 5/00 A, 7G 02B 5/23 B, 7G 01J 1/50 B

17Q First examination report despatched

Effective date: 20070918

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080329